Linezolid use and safe practices

Linezolid is active against gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA), β-lactam-resistant streptococci, and vancomycin-resistant enterococci (VRE).[1][1] Additionally, linezolid is a component of several regimens for treatment of drug-resistant

Authors

Institutions

Publication Details

Journal
Canadian Medical Association Journal
Published
2025-04-06
DOI
https://doi.org/10.1503/cmaj.241220
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Linezolid use and safe practices

P. Bunce, Mei-Ni Belzile
Canadian Medical Association Journal
Antimicrobial Resistance in Staphylococcus
article

Linezolid use and safe practices

P. Bunce, Mei-Ni Belzile
article en

Abstract

Linezolid is active against gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA), β-lactam-resistant streptococci, and vancomycin-resistant enterococci (VRE).[1][1] Additionally, linezolid is a component of several regimens for treatment of drug-resistant

Canadian Medical Association JournalVol. 197(13)
Sinai Health System (CA)
Zero hunger
Openalex Percentile: Top 90%
Antimicrobial Resistance in Staphylococcus
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.